Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of alogliptin plus metformin versus monotherapy in type 2 diabetes mellitus
2009-012652-24Phase 3Completed
- Sponsor
- Takeda
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of alogliptin and metformin in type 2 diabetes mellitus (T2DM) (5 arms), sponsored by Takeda. Primary endpoint: Primary HbA1c change at Week 26. Started Jan 2010; status: completed.
02
Drugs
alogliptinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2009-012652-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012652-24.